🇺🇸 FDA
Patent

US 7695627

Tangential flow filtration devices and methods for leukocyte enrichment

granted A61PA61P37/02

Quick answer

US patent 7695627 (Tangential flow filtration devices and methods for leukocyte enrichment) held by Northwest Biotherapeutics, Inc. expires Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwest Biotherapeutics, Inc.
Grant date
Tue Apr 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
45
CPC classes
A61P, A61P37/02